Publication:
Poikilodermatous mycosis fungoides with CD30-positive large cell transformation successfully treated by brentuximab vedotin

Simple item page
dc.contributor.authorPopadic, Svetlana (24830928800)
dc.contributor.authorLekic, Branislav (56092444000)
dc.contributor.authorTanasilovic, Srdjan (24169980600)
dc.contributor.authorBosic, Martina (56606207600)
dc.contributor.authorNikolic, Milos (56910382000)
dc.date.accessioned2025-06-12T14:54:05Z
dc.date.available2025-06-12T14:54:05Z
dc.date.issued2020
dc.description.abstractWe present a patient with a 33-year history of poikilodermatous mycosis fungoides (MF) who subsequently developed CD30-positive large cell transformation. After 6 years of conventional MF treatment, side effects of therapy and/or concomitant diseases prevented the previously applied treatment modalities. The CD30-directed antibody-cytotoxic drug conjugate (brentuximab vedotin) was introduced and followed by quick and excellent therapeutic response. © 2019 Wiley Periodicals, Inc.
dc.identifier.urihttps://doi.org/10.1111/dth.13152
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85075375829&doi=10.1111%2fdth.13152&partnerID=40&md5=90f2b99153e3125c1a62534ddf1fbf96
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/5340
dc.subjectbrentuximab vedotin
dc.subjectCD30-positive large cell transformation
dc.subjectmycosis fungoides
dc.titlePoikilodermatous mycosis fungoides with CD30-positive large cell transformation successfully treated by brentuximab vedotin
dspace.entity.typePublication

Files

Collections

Publikacije / Publications